ALS Metabolic Pathway Discovered Using Biolog Phenotyping Technology

ALS Metabolic Pathway Discovered Using Biolog Phenotyping Technology

Researchers at the University of Sheffield have identified a new pathway that is disrupted in amyotrophic lateral sclerosis (ALS). The discovery was enabled by converting skin cells to brain cells called astrocytes and comparing the energy metabolism of cells taken from ALS versus normal controls, using Biolog’s Metabolic Phenotyping Technology. The scientists discovered the loss of a key enzyme that could have major consequences for how the central nervous system copes with aging, stress and loss of energy metabolism.

0Shares

About Us

Biolog is a world leader in cell-based phenotypic testing technologies and assays. We have focused our efforts on developing technologies and products to test properties of cells (phenotypes) very simply and efficiently.